<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>advanced medical technologies - Latest Comments</title><link xmlns="http://www.w3.org/2005/Atom" rel="http://api.friendfeed.com/2008/03#sup" href="http://disqus.com/sup/all.sup#forumcomments-a184af8d" type="application/json"/><link>http://medmarket.disqus.com/</link><description>opinions, insights and inside data from founder of MedMarket Diligence</description><atom:link href="http://medmarket.disqus.com/comments.rss" rel="self"></atom:link><language>en</language><lastBuildDate>Thu, 19 Jan 2012 09:58:19 -0000</lastBuildDate><item><title>Re: Degenerative disc diseases, implications for spinal surgery technolologies</title><link>http://mediligence.com/blog/2009/02/16/degenerative-disc-diseases/#comment-415350119</link><description>The other type of back and leg pain is chronic, lasting for more than two months.&lt;br&gt;There are two generations of back disc symptoms and leg pain. One is acute or short term back and leg pain which usualy last from periods of a few days to a few weeks.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kencoach1202</dc:creator><pubDate>Thu, 19 Jan 2012 09:58:19 -0000</pubDate></item><item><title>Re: Competition, investment and markets in cell therapy, tissue engineering</title><link>http://mediligence.com/blog/2012/01/14/competition-investment-and-markets-in-cell-therapy-tissue-engineering/#comment-411206256</link><description>Historic and current (2010 at the time of the analysis) revenues are based on actual manufacturer sales.  Forecast revenues are based on conservative trending of historic sales combined with rates of clinical adoption, specific anticipated new products and other measurable events.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Sat, 14 Jan 2012 13:31:44 -0000</pubDate></item><item><title>Re: FDA accepts NDA for VIVUS&amp;#8217; Qnexa</title><link>http://mediligence.com/blog/2011/11/04/fda-accepts-nda-for-vivus-qnexa/#comment-387149939</link><description>Glad to see the fda is letting &lt;a href="http://www.mf3swiss.com/index.php" rel="nofollow"&gt;cell therapy&lt;/a&gt; to move forward</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mikeware386</dc:creator><pubDate>Thu, 15 Dec 2011 08:14:47 -0000</pubDate></item><item><title>Re: Tissue engineering and cell therapy future markets</title><link>http://mediligence.com/blog/2011/10/24/tissue-engineering-and-cell-therapy-future-markets/#comment-387148985</link><description>I'm glad to see &lt;a href="http://www.mf3swiss.com/index.php" rel="nofollow"&gt;cell therapy&lt;/a&gt; moving forward but i still think the research is behind where it should be..</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mikeware386</dc:creator><pubDate>Thu, 15 Dec 2011 08:12:27 -0000</pubDate></item><item><title>Re: Radiofrequency ablation market continued growth strong globally</title><link>http://mediligence.com/blog/2011/05/13/radiofrequency-ablation-market-continued-growth-strong-globally/#comment-386630250</link><description>I understand your interest in the actual percentages, but since we sell proprietary research reports, the information in this blog is only intended to provide highlights of the full analyses, which are available from us for purchase.  If it would help, I can tell you that the Covidien/Valleylab share here was 30% and Medtronic's was 22%.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Wed, 14 Dec 2011 14:02:09 -0000</pubDate></item><item><title>Re: Radiofrequency ablation market continued growth strong globally</title><link>http://mediligence.com/blog/2011/05/13/radiofrequency-ablation-market-continued-growth-strong-globally/#comment-386604043</link><description>If you went to the trouble of including a market share pie chart, why not be helpful and display the actual share percentages?</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">PHP</dc:creator><pubDate>Wed, 14 Dec 2011 13:22:37 -0000</pubDate></item><item><title>Re: European Obesity Drug and Device Markets</title><link>http://mediligence.com/blog/2011/11/14/european-obesity-drug-and-device-markets/#comment-370068128</link><description>All numbers are based on actual sales, projected growth of sales or sales ensuing from specific product introductions. See &lt;a href="http://www.mediligence.com/rpt/rpt-s835.htm" rel="nofollow"&gt;http://www.mediligence.com/rpt...&lt;/a&gt;. Patrick Driscoll&lt;br&gt;MedMarket Diligence, LLC&lt;br&gt;+1.949.859.3401&lt;br&gt;+1.949.837.4558 fax&lt;br&gt;&lt;a href="http://www.mediligence.com" rel="nofollow"&gt;www.mediligence.com&lt;/a&gt;&lt;br&gt;&lt;a href="http://mediligence.com/blog" rel="nofollow"&gt;mediligence.com/blog&lt;/a&gt;&lt;br&gt;&lt;a href="http://twitter.com/medmarket" rel="nofollow"&gt;twitter.com/medmarket&lt;/a&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Tue, 22 Nov 2011 09:19:23 -0000</pubDate></item><item><title>Re: European Obesity Drug and Device Markets</title><link>http://mediligence.com/blog/2011/11/14/european-obesity-drug-and-device-markets/#comment-369950510</link><description>How are you taking those rates in 2018, do you have any numbers to base on?</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">gestt</dc:creator><pubDate>Tue, 22 Nov 2011 04:39:57 -0000</pubDate></item><item><title>Re: Size and Growth of Tissue Engineering and Cell Therapy in the U.S., Europe, Asia/Pacific and Rest of World</title><link>http://mediligence.com/blog/2010/03/16/size-and-growth-of-tissue-engineering-in-the-u-s-europe-asiapacific-and-rest-of-world/#comment-357480950</link><description>The x-axis (horizontal) is the compound annual growth rate of the market.  The y-axis is the global market in millions of dollars.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Mon, 07 Nov 2011 09:38:19 -0000</pubDate></item><item><title>Re: Size and Growth of Tissue Engineering and Cell Therapy in the U.S., Europe, Asia/Pacific and Rest of World</title><link>http://mediligence.com/blog/2010/03/16/size-and-growth-of-tissue-engineering-in-the-u-s-europe-asiapacific-and-rest-of-world/#comment-357386057</link><description>what does reflect the X axis, please. Thank you&lt;br&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hpetite</dc:creator><pubDate>Mon, 07 Nov 2011 04:25:47 -0000</pubDate></item><item><title>Re: Diseases, trauma and technologies for spine surgery</title><link>http://mediligence.com/blog/2011/05/10/diseases-trauma-and-technologies-for-spine-surgery/#comment-348773719</link><description>Did your Neurologist do an EMG yet to see if a neural is being pressurized in your hands or leg yet. I would also obtain a Orthosurgeon or Neurosurgeon to see what their cure is and can let you know if it`s necessary to have surgical procedures. Get more than one viewpoint and trust you may obtain a Dr. to help soon.&lt;a href="http://jamesmakker.portlandneurosurgeons.net/" rel="nofollow"&gt;James Makker, MD&lt;/a&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Warren</dc:creator><pubDate>Sat, 29 Oct 2011 09:54:22 -0000</pubDate></item><item><title>Re: Surgical wound closure and securement, market size versus growth</title><link>http://mediligence.com/blog/2009/06/03/surgical-wound-closure-and-securement-market-size-versus-growth/#comment-315082753</link><description>We have the sealants, glues, hemostasis, other wound closure and anti-adhesion market data detailed in a forecast to 2015, with breakdowns by country: US, United Kingdom, Germany, France, Italy, Japan, Korea and Rest of World.  See the report #S247: &lt;a href="http://www.mediligence.com/rpt/rpt-s180.htm" rel="nofollow"&gt;http://www.mediligence.com/rpt...&lt;/a&gt;.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Mon, 19 Sep 2011 13:40:50 -0000</pubDate></item><item><title>Re: Surgical wound closure and securement, market size versus growth</title><link>http://mediligence.com/blog/2009/06/03/surgical-wound-closure-and-securement-market-size-versus-growth/#comment-315080481</link><description>Any updates to this chart?  Any additional break down info?&lt;br&gt;&lt;br&gt;Thanks!</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Holydoggie</dc:creator><pubDate>Mon, 19 Sep 2011 13:36:52 -0000</pubDate></item><item><title>Re: Obesity Treatment Device Market Outlook</title><link>http://mediligence.com/blog/2011/09/12/obesity-treatment-device-market-outlook/#comment-313207179</link><description>What a completely idiotic comment.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Fri, 16 Sep 2011 10:24:53 -0000</pubDate></item><item><title>Re: Obesity Treatment Device Market Outlook</title><link>http://mediligence.com/blog/2011/09/12/obesity-treatment-device-market-outlook/#comment-313194299</link><description>That is understood but that sounds like destabilization of a society.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Justin Smith</dc:creator><pubDate>Fri, 16 Sep 2011 09:58:25 -0000</pubDate></item><item><title>Re: Obesity Treatment Device Market Outlook</title><link>http://mediligence.com/blog/2011/09/12/obesity-treatment-device-market-outlook/#comment-308045869</link><description>Keep in mind that these devices are FDA-regulated -- they would only be implanted or otherwise used at the direction of a physician.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Mon, 12 Sep 2011 15:48:08 -0000</pubDate></item><item><title>Re: Obesity Treatment Device Market Outlook</title><link>http://mediligence.com/blog/2011/09/12/obesity-treatment-device-market-outlook/#comment-308030460</link><description>I found this very interesting as since the projected demographic shows diet suppression which seems almost dangerous if one thinks about that, as far as a societies health that is dictated by supplemental devices.&lt;br&gt;&lt;br&gt;Justin Smith&lt;br&gt;&lt;a href="http://www.FrontlineMobility.com" rel="nofollow"&gt;http://www.FrontlineMobility.c...&lt;/a&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Justin Smith</dc:creator><pubDate>Mon, 12 Sep 2011 15:20:26 -0000</pubDate></item><item><title>Re: Materials used in stent construction</title><link>http://mediligence.com/blog/2009/06/11/materials-used-in-stent-construction/#comment-287429922</link><description>No, this is not a deep review.  It is just an excerpt from a nearly 300 page business report on coronary stents.  See &lt;a href="http://www.mediligence.com/rpt/rpt-c245.htm" rel="nofollow"&gt;http://www.mediligence.com/rpt...&lt;/a&gt;.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Mon, 15 Aug 2011 18:12:08 -0000</pubDate></item><item><title>Re: Materials used in stent construction</title><link>http://mediligence.com/blog/2009/06/11/materials-used-in-stent-construction/#comment-287383651</link><description>Very good recopilation of different material used in stents fabrication and also a not deep review about biocompatibility is a good start to began ti research</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fernando Pastrana</dc:creator><pubDate>Mon, 15 Aug 2011 17:17:11 -0000</pubDate></item><item><title>Re: Pressure Ulcer Staging and Management</title><link>http://mediligence.com/blog/2010/05/06/pressure-ulcer-staging-and-management/#comment-278345904</link><description>That was very informative. I learned so much from this article.  And I remember someone mentioning to me before that malnutrition can also be one of the cause? How true is this?</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Medicare Advantage 2012  </dc:creator><pubDate>Fri, 05 Aug 2011 10:36:08 -0000</pubDate></item><item><title>Re: Wound management technology projections</title><link>http://mediligence.com/blog/2011/03/21/wound-management-technology-projections/#comment-277421963</link><description>Thank you for taking the time to put this all together. I learned a lot of good points from them.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Medicare Advantage 2012  </dc:creator><pubDate>Thu, 04 Aug 2011 12:05:04 -0000</pubDate></item><item><title>Re: Global wound care market segmentation, drivers</title><link>http://mediligence.com/blog/2009/10/21/global-wound-care-market-segmentation-drivers/#comment-275853537</link><description>What do you consider the laparotomy "market" to be?  Laparotomy is a surgical procedure involved in general surgery of the abdomen.  The Wound Management Market report (&lt;a href="http://www.mediligence.com/rpt/rpt-s247.htm)" rel="nofollow"&gt;http://www.mediligence.com/rpt...&lt;/a&gt; covers products used for this purpose.  The report covers products used in the management of surgical and non-surgical wounds.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Wed, 03 Aug 2011 01:31:57 -0000</pubDate></item><item><title>Re: Global wound care market segmentation, drivers</title><link>http://mediligence.com/blog/2009/10/21/global-wound-care-market-segmentation-drivers/#comment-275842189</link><description>is Laparotomy market covered in the Wound management market?</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kommalik</dc:creator><pubDate>Wed, 03 Aug 2011 00:55:55 -0000</pubDate></item><item><title>Re: High Strength Medical/Surgical Glue Opportunity</title><link>http://mediligence.com/blog/2010/10/13/high-strength-medicalsurgical-glue-opportunity/#comment-263436262</link><description>Details on purchasing the report are found at &lt;a href="http://www.mediligence.com/rpt/rpt-s180.htm" rel="nofollow"&gt;http://www.mediligence.com/rpt...&lt;/a&gt;.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">pdriscoll</dc:creator><pubDate>Mon, 25 Jul 2011 09:39:19 -0000</pubDate></item><item><title>Re: High Strength Medical/Surgical Glue Opportunity</title><link>http://mediligence.com/blog/2010/10/13/high-strength-medicalsurgical-glue-opportunity/#comment-263308202</link><description>how can i purchase it</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Supergranmoe</dc:creator><pubDate>Mon, 25 Jul 2011 03:01:55 -0000</pubDate></item></channel></rss>
